These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32439936)

  • 41. Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression.
    Ratajczak-Wielgomas K; Kmiecik A; Dziegiel P
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pirin Promotes the Progression of Non-Small-Cell Lung Cancer by Increasing ODC1 to Suppress Autophagy.
    Li YP; Huang ZJ; He QK; Li YX; Zhao XP; Ma ZQ; Qin MJ; Chen AW; Wei Q; Wang Y; Lu CH
    J Proteome Res; 2024 May; 23(5):1713-1724. PubMed ID: 38648079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
    Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
    Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A; Tu Z; Yin B
    Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression.
    Lei W; Kang W; Nan Y; Lei Z; Zhongdong L; Demin L; Lei S; Hairong H
    Oncol Res; 2018 Aug; 26(7):1015-1022. PubMed ID: 29321091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
    Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
    J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA DUXAP9-206 directly binds with Cbl-b to augment EGFR signaling and promotes non-small cell lung cancer progression.
    Zhu T; An S; Choy MT; Zhou J; Wu S; Liu S; Liu B; Yao Z; Zhu X; Wu J; He Z
    J Cell Mol Med; 2019 Mar; 23(3):1852-1864. PubMed ID: 30515972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
    Wang M; Wang W; Ding J; Wang J; Zhang J
    Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.
    Feng Y; Gao Y; Yu J; Jiang G; Zhang X; Lin X; Han Q; Rong X; Xu H; Li Q; Qiu X; Wang E
    Mol Carcinog; 2019 Jan; 58(1):126-134. PubMed ID: 30242906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of LINC00342 as a poor prognostic biomarker for human patients with non-small cell lung cancer.
    Tang H; Zhao L; Li M; Li T; Hao Y
    J Cell Biochem; 2019 Apr; 120(4):5055-5061. PubMed ID: 30320899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer.
    Huang C; Ma R; Yue J; Li N; Li Z; Qi D
    Cell Physiol Biochem; 2015; 37(1):342-52. PubMed ID: 26316081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Actin Filament-Associated Protein 1-Like 1 Mediates Proliferation and Survival in Non-Small Cell Lung Cancer Cells.
    Wang M; Han X; Sun W; Li X; Jing G; Zhang X
    Med Sci Monit; 2018 Jan; 24():215-224. PubMed ID: 29323101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
    Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
    BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
    Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
    Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
    Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
    Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
    Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.